Becton, Dickinson and Company (0R19.L)
USD 167.54
(-4.69%)
USD 167.54
(-4.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 19.37 Billion USD | 2.66% |
| 2022 | 18.87 Billion USD | -1.36% |
| 2021 | 19.13 Billion USD | 19.02% |
| 2020 | 16.07 Billion USD | -0.89% |
| 2019 | 16.21 Billion USD | 1.47% |
| 2018 | 15.98 Billion USD | 32.17% |
| 2017 | 12.09 Billion USD | -3.12% |
| 2016 | 12.48 Billion USD | 21.41% |
| 2015 | 10.28 Billion USD | 21.74% |
| 2014 | 8.44 Billion USD | 4.87% |
| 2013 | 8.05 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.7 Billion USD | -7.49% |
| 2024 Q3 | 4.99 Billion USD | -1.09% |
| 2024 Q2 | 5.04 Billion USD | 7.2% |
| 2023 Q3 | 4.87 Billion USD | 1.18% |
| 2023 Q2 | 4.82 Billion USD | 5.12% |
| 2023 FY | 19.37 Billion USD | 2.66% |
| 2023 Q1 | 4.58 Billion USD | -3.68% |
| 2023 Q4 | 5.08 Billion USD | 4.28% |
| 2022 FY | 18.87 Billion USD | -1.36% |
| 2022 Q4 | 4.76 Billion USD | 2.59% |
| 2022 Q3 | 4.64 Billion USD | -7.38% |
| 2022 Q2 | 5.01 Billion USD | 0.32% |
| 2022 Q1 | 4.99 Billion USD | -2.73% |
| 2021 Q1 | 5.31 Billion USD | 11.1% |
| 2021 Q3 | 4.89 Billion USD | 12.16% |
| 2021 FY | 19.13 Billion USD | 19.02% |
| 2021 Q4 | 5.13 Billion USD | 5.01% |
| 2021 Q2 | 4.36 Billion USD | -17.97% |
| 2020 Q3 | 3.85 Billion USD | -9.36% |
| 2020 Q4 | 4.78 Billion USD | 24.1% |
| 2020 FY | 16.07 Billion USD | -0.89% |
| 2020 Q2 | 4.25 Billion USD | 0.66% |
| 2020 Q1 | 4.22 Billion USD | -7.83% |
| 2019 Q2 | 4.19 Billion USD | 0.84% |
| 2019 FY | 16.21 Billion USD | 1.47% |
| 2019 Q4 | 4.58 Billion USD | 5.38% |
| 2019 Q3 | 4.35 Billion USD | 3.69% |
| 2019 Q1 | 4.16 Billion USD | -5.5% |
| 2018 FY | 15.98 Billion USD | 32.17% |
| 2018 Q4 | 4.4 Billion USD | 2.9% |
| 2018 Q3 | 4.27 Billion USD | 1.33% |
| 2018 Q2 | 4.22 Billion USD | 37.08% |
| 2018 Q1 | 3.08 Billion USD | -2.72% |
| 2017 Q4 | 3.16 Billion USD | 4.32% |
| 2017 FY | 12.09 Billion USD | -3.12% |
| 2017 Q1 | 2.92 Billion USD | -9.56% |
| 2017 Q2 | 2.96 Billion USD | 1.61% |
| 2017 Q3 | 3.03 Billion USD | 2.22% |
| 2016 Q2 | 3.06 Billion USD | 2.71% |
| 2016 Q3 | 3.19 Billion USD | 4.27% |
| 2016 Q1 | 2.98 Billion USD | -2.42% |
| 2016 Q4 | 3.23 Billion USD | 1.03% |
| 2016 FY | 12.48 Billion USD | 21.41% |
| 2015 Q2 | 2.05 Billion USD | 0.0% |
| 2015 Q1 | 2.05 Billion USD | -6.26% |
| 2015 FY | 10.28 Billion USD | 21.74% |
| 2015 Q4 | 3.06 Billion USD | -1.92% |
| 2015 Q3 | 3.12 Billion USD | 52.12% |
| 2014 Q3 | 2.15 Billion USD | 4.1% |
| 2014 Q2 | 2.07 Billion USD | 2.83% |
| 2014 Q1 | 2.01 Billion USD | -4.09% |
| 2014 FY | 8.44 Billion USD | 4.87% |
| 2014 Q4 | 2.18 Billion USD | 1.44% |
| 2013 Q2 | 2 Billion USD | 5.26% |
| 2013 Q1 | 1.9 Billion USD | 0.0% |
| 2013 Q4 | 2.1 Billion USD | 2.34% |
| 2013 FY | 8.05 Billion USD | 0.0% |
| 2013 Q3 | 2.05 Billion USD | 2.65% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -5337.007% |
| Accuray Incorporated | 446.55 Million USD | -4238.138% |
| Align Technology, Inc. | 3.86 Billion USD | -401.572% |
| Elevance Health Inc. | 171.34 Billion USD | 88.694% |
| AxoGen, Inc. | 159.01 Million USD | -12082.728% |
| Boston Scientific Corporation | 14.24 Billion USD | -36.039% |
| CVS Health Corporation | 357.77 Billion USD | 94.585% |
| Cardinal Health, Inc. | 226.82 Billion USD | 91.46% |
| Centene Corporation | 141.26 Billion USD | 86.287% |
| DaVita Inc. | 12.14 Billion USD | -59.57% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 70.182% |
| Hologic, Inc. | 4.03 Billion USD | -380.659% |
| Humana Inc. | 106.37 Billion USD | 81.789% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -429.152% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -59.288% |
| Masimo Corporation | 2.04 Billion USD | -845.852% |
| McKesson Corporation | 308.95 Billion USD | 93.73% |
| Patterson Companies, Inc. | 6.56 Billion USD | -194.933% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -109.382% |
| ResMed Inc. | 4.68 Billion USD | -313.464% |
| Henry Schein, Inc. | 12.33 Billion USD | -56.998% |
| Teladoc Health, Inc. | 2.6 Billion USD | -644.386% |
| Universal Health Services, Inc. | 14.28 Billion USD | -35.639% |
| Veeva Systems Inc. | 2.36 Billion USD | -719.572% |
| Baxter International Inc. | 14.81 Billion USD | -30.777% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -171.922% |
| Danaher Corporation | 23.89 Billion USD | 18.912% |
| Stryker Corporation | 20.49 Billion USD | 5.493% |
| Medtronic plc | 32.36 Billion USD | 40.143% |